Maplelane Capital’s Canopy Growth CGC Stock Holding History

Maplelane Capital’s Portfolio CGC Stock Details CGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,000	Closed	-$1.06M	–	50
2022 Q1	$1.06M	Buy	+14,000	New	+$1.07M	0.03%	56

Other funds holding CGC

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Maplelane Capital's CGC Position: Q2 2022 in Review

Maplelane Capital sold out of Canopy Growth (CGC) in Q2 2022, closing a stake of 14,000 shares — an estimated $1.06M sold.

Maplelane Capital first reported a position in CGC in Q1 2022 and held it in 1 quarter. The position peaked at $1.06M in Q1 2022. 367 funds tracked by Wall St. Rank hold CGC as of Q2 2022.

Maplelane Capital reported no remaining Canopy Growth position as of Q2 2022 after selling out during the quarter.
Maplelane Capital sold 14,000 Canopy Growth shares in Q2 2022, an estimated $1.06M.
Maplelane Capital first reported a position in Canopy Growth in Q1 2022 and held it in 1 quarter.
Maplelane Capital's Canopy Growth position peaked at $1.06M in Q1 2022.
367 funds tracked by Wall St. Rank held Canopy Growth as of Q2 2022.

Based on Maplelane Capital's 13F filing for Q2 2022, filed 15 Aug 2022.